Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE

World Journal of Gastroenterology

Volumn 8, Issue 4, 2002, Pages 658-662

  Yan, Fu Hua ^a   Zhou, Kang Rong ^a   Cheng, Jie Min ^a   Wang, Jian Hua ^a   Yan, Zhi Ping ^a   Da, Reng Rong ^a   Fan, Jia ^a   Ji, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIAOROUBIXING; CISPLATIN; FLUOROURACIL; GELATIN SPONGE; IODINATED POPPYSEED OIL; MITOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FAST MULTIPLANAR SPOILED GRADIENT RECALLED MAGNETIC RESONANCE DYNAMIC CONTRAST SCANNING; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HEMORRHAGE; LIVER HISTOLOGY; LIVER NECROSIS; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0036678963     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i4.658     Document Type: Article

References (58)

1. The prognostic significance of clinical and pathological features in hepatocellular carcinoma
2. Progress in research of liver surgery in China
3. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein
4. Hepatocellular carcinoma-cause, treatment and metastasis
5. Liver resection for cancer
6. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma
7. Diagnostic imaging and interventional therapy of hepatocellular carcinoma
8. Treatment of hepatocellular carcinoma by interventional methods
9. Three-year follow-up of 62 cirrhotic patients with h nepatocellular carcinoma treated with chemoembolization
10. Effect of post-operative survival rate with pre-operative transcatheter arterial chemoembolization in the patients with resectable hepatocellular carcinoma
11. Transarterial chemoembolization (TACE) of liver metastases. A palliative therapeutic approach
12. Treatment of hepatocellular carcinoma by transcantheter arterial chemoembolzation with hydroxycamptothecin
13. Effects of angiogenesis inhibitor TNP-470 with lipiodol in arterial embolization of liver cancer in rabbits
14. A retrospective review on interventional treatment of 10000 cases of liver cancer
15. Treatment of hepatocellular carcinoma by hepatic arterial chemoembolization in 58 cases
16. Hepatic arterial infusion chemotherapy and embolization in the treatment of primary hepatic carcinoma
17. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: Local therapeutic effect and long-term survival rate
18. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization
19. Arterial chemoembolization for hepatocellular carcinoma
20. Segmental transcatheter arterial embolization for primary hepatocellular carcinoma
21. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Group CHC
22. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - A single-center analysis including 132 patients
23. Stage II surgical resection of hepatocellular carcinoma after TAE: A report of 38 cases
24. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
25. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma
26. Practical management of hepatocellular carcinoma
27. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study
28. Palliative treatment of hepatocellular carcinoma by chemoembolization
29. Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol
30. Non-surgical treatment of hepatocellular carcinoma
31. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: An evaluation of the local therapeutic effect and survival rate
32. Imaging diagnosis of micro liver cancer in China
33. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma
34. MR imaging techniques of the liver
35. Primary hepatic malignant neoplasms
36. The comparative study of the enhancement patterns of SHCC with dynamic MRI and dynamic CT
37. Evaluation of dynamic enhanced fast multiplanner spoiling gradient-recalled in the diagnosis of small hepatocellular carcinoma
38. Comparative study of spiral CT, dynamic MRI and US for diagnosis of small hepatocellular carcinoma
39. MR imaging of hepatocellular carcinoma
40. Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: Correlation of dynamic susceptibility contrast-enhanced echo plannar imaging and hepatic angiography
41. Study of the liver and the portal venous system with digital rotational angiography
42. Therapeutic effect of transcatheter oil chemoembolization therapy for encapsulated nodular hepatic carcinoma: CT and pathologic findings
43. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma
44. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - Results from a liver transplantation center
45. Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: A retrospective analysis
46. Intrahepatic metastatic nodules of hepatocellular carcinoma detected at lipiodol-CT: Imaging-pathologic correlation
47. Hepatocellular carcinoma in cirrhosis: Semeiology and performance of magnetic resonance imaging and lipiodol computed tomography
48. Multiphasic helical computed tomography of hepatocarcinoma. Assessment after chemoembolization
49. Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma
50. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization
51. Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology
52. Dynamic MR imaging of hepatoma by transcatheter arterial embolization therapy. Assessment of treatment effect
53. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization
54. Hepatocellular carcinoma: CT and MR features after transcatheter arterial chemoembolization and percutaneous ethanol injection
55. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization
56. Malignant hepatic tumors: Changed on MRI after hepatic arterial chemoembolization - Preliminary findings
57. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: Comparison of lipiodol-CT, power Doppler sonography, and dynamic MRI
58. Detection of hepatic tumor perfusion following transcatheter arterial chemoembolization with dynamic susceptibility contras-enhanced echoplannar imaging